Abstract
Objective: It remains controversial whether non-malignant ‘benign’ hypertension causes renal dysfunction. The effect of lowering blood pressure on the incidence of renal dysfunction among patients with non-malignant hypertension is not clear. This meta-analysis was conducted to determine whether antihypertensive drug therapy reduces the incidence of renal dysfunction in patients with non-malignant hypertension.
Methods: Randomised, controlled trials of antihypertensive drug therapy of more than 1 year duration that reported renal dysfunction as an outcome were identified through MEDLINE search and literature review. A random effects model was used to obtain summary estimates.
Results: Ten trials were identified, involving 26 521 individuals and 114 000 person-years. All excluded subjects with advanced baseline renal disease. Definition of renal dysfunction outcome varied among trials but within each trial was applied similarly to both treatment and control groups. Drug treatment consisted mostly of diuretics and adrenergic blockers. Overall, treated patients had lower blood pressure and fewer cardiovascular events. There were a total of 317 cases of renal dysfunction. Patients randomised to antihypertensive therapy (or more intensive therapy) did not have a significant reduction in their risk of developing renal dysfunction (relative risk = 0.97; 95% confidence interval (CI) 0.78–1.21; P = 0.77).
Conclusions: Among patients with non-malignant hypertension enrolled in randomised trials, treated patients did not have a lower risk of renal dysfunction. The 95% CI suggests that a 25% or more true protective effect of antihypertensive drugs is unlikely.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hsu, C. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens 15, 99–106 (2001). https://doi.org/10.1038/sj.jhh.1001128
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001128
Keywords
This article is cited by
-
Ambulatory blood pressure as risk factor for long-term kidney function decline in the general population: a distributional regression approach
Scientific Reports (2023)
-
Blood pressure and age-related GFR decline in the general population
BMC Nephrology (2017)
-
Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population
Clinical and Experimental Nephrology (2014)
-
Treatment of Hypertension With Renin-Angiotensin System Inhibitors and Renal Dysfunction: A Systematic Review and Meta-Analysis
American Journal of Hypertension (2012)
-
Hypertension: The kidney is the culprit even in the absence of kidney disease
Kidney International (2007)